Literature DB >> 6977209

Trimethoprim-sulphamethoxazole in the treatment of enteric fever in the Sudan.

E D Mukhtar, M O Mekki.   

Abstract

Patients with enteric fever confirmed by isolation of Salmonella species from blood culture, were treated with the combination of trimethoprim-sulphamethoxazole (co-trimoxazole). All 133 patients responded well to treatment. The mean defervescence was 2.74 days. No serious side effects were noticed and relapses occurred in the patients during the period of follow up.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6977209     DOI: 10.1016/0035-9203(81)90407-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.

Authors:  J Escamilla; M E Kilpatrick; H F Ugarte
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.

Authors:  M Trautmann; B Krause; D Birnbaum; J Wagner; V Lenk
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

3.  Prevalence of current patterns and predictive trends of multidrug-resistant Salmonella Typhi in Sudan.

Authors:  Ayman A Elshayeb; Abdelazim A Ahmed; Marmar A El Siddig; Adil A El Hussien
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-14       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.